{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:42:46Z","timestamp":1791924166730,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.radonc.2018.06.018","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T01:59:15Z","timestamp":1530151155000},"page":"260-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)"],"prefix":"10.1016","volume":"128","author":[{"given":"Damien C.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia M.","family":"Peerdeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurette","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta G.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Miralbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Stelmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.06.018_b0005","series-title":"Pathology and genetics tumor of the nervous system","first-page":"176","article-title":"Meningiomas","author":"Louis","year":"2000"},{"key":"10.1016\/j.radonc.2018.06.018_b0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/WCO.0b013e328340441e","article-title":"New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright","volume":"23","author":"Weber","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.radonc.2018.06.018_b0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1005853720926","article-title":"Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy","volume":"37","author":"Dziuk","year":"1998","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0020","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000000490","article-title":"The 2016 WHO classification of central nervous system tumors: what neurologists need to know","author":"DeWitt","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.radonc.2018.06.018_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2017.08.005","article-title":"Long-term clinical outcomes of pencil beam scanning proton therapy for benign and non-benign intracranial meningiomas","author":"Murray","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.018_b0030","first-page":"2","article-title":"Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma","volume":"31","author":"Kallio","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2018.06.018_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1994.80.2.0195","article-title":"Larson Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990","volume":"80","author":"Goldsmith","year":"1994","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0360-3016(95)02166-3","article-title":"Radiotherapy for atypical or malignant intracranial meningioma","volume":"34","author":"Milosevic","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.018_b0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006434124794","article-title":"Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy","volume":"48","author":"Hug","year":"2000","journal-title":"J Neurooncol."},{"key":"10.1016\/j.radonc.2018.06.018_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1005981731739","article-title":"Atypical and malignant meningiomas: an outcome report of seventeen cases","volume":"39","author":"Coke","year":"1998","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0055","article-title":"Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy","author":"Masalha","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0060","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/neuonc\/nou149","article-title":"Radiotherapy versus observation following surgical resection of atypical meningioma (the ROAM trial)","volume":"16","author":"Jenkinson","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.radonc.2018.06.018_b0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1748-717X-8-23","article-title":"Quality assurance of radiotherapy in the ongoing EORTC 22042-26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews","volume":"8","author":"Coskun","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0080","article-title":"Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539","volume":"1\u201313","author":"Rogers","year":"2017","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2007.12.020","article-title":"Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the rare cancer network","author":"Pasquier","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.018_b0090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2005.077974","article-title":"Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification","volume":"77","author":"Simon","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.radonc.2018.06.018_b0095","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/02688690802308687","article-title":"Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?","volume":"22","author":"Marcus","year":"2008","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s13063-015-1040-3","article-title":"The ROAM\/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial","volume":"16","author":"Jenkinson","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.radonc.2018.06.018_b0105","doi-asserted-by":"crossref","DOI":"10.3171\/2012.7.JNS112113","article-title":"The role of radiotherapy following gross-total resection of atypical meningiomas","author":"Komotar","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1227\/01.NEU.0000330399.55586.63","article-title":"Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation","volume":"64","author":"Aghi","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2018.06.018_b0115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3171\/2011.5.JNS11112","article-title":"Radiotherapy for atypical meningiomas","volume":"115","author":"Mair","year":"2011","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0120","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jocn.2010.03.036","article-title":"Treatment of atypical meningioma","volume":"17","author":"Jo","year":"2010","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.radonc.2018.06.018_b0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3171\/2012.7.JNS111439","article-title":"Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis","volume":"117","author":"Stessin","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2018.06.018_b0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-007-9366-7","article-title":"Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients","volume":"84","author":"van Nieuwenhuizen","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0135","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ijrobp.2004.12.048","article-title":"Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons","volume":"62","author":"Noel","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.018_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jocn.2016.02.002","article-title":"Meningioma after radiotherapy for malignancy","volume":"30","author":"Morgenstern","year":"2016","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.radonc.2018.06.018_b0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2008.03.025","article-title":"EORTC 22972\u201326991\/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm","volume":"88","author":"Baumert","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2012.04.002","article-title":"Quality assurance in the EORTC 22033\u201326033\/CE5 phase III randomized trial for low grade glioma: the digital individual case review","volume":"103","author":"Fairchild","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13014-015-0384-x","article-title":"Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma","volume":"10","author":"Madani","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2014.05.047","article-title":"Cognitive dysfunction might be improved in association with recovered neuronal viability after intracranial meningioma resection","volume":"1574","author":"Koizumi","year":"2014","journal-title":"Brain Res"},{"key":"10.1016\/j.radonc.2018.06.018_b0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-017-2495-8","article-title":"Neurocognition in individuals with incidentally-identified meningioma","volume":"134","author":"Butts","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0175","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/jnnp.2007.138925","article-title":"Late neurocognitive sequelae in patients with WHO grade I meningioma","volume":"80","author":"Dijkstra","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.radonc.2018.06.018_b0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1227\/NEU.0b013e318212badb","article-title":"Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas","volume":"69","author":"Waagemans","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.radonc.2018.06.018_b0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/neuonc\/5.2.89","article-title":"Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression","volume":"5","author":"Meyers","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2018.06.018_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)31442-3","article-title":"Interim results from the CATNON trial (EORTC study 26053\u201322054) of treatment with concurrent and adjuvant temozolomide for 1p\/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study","author":"van den Bent","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2018.06.018_b0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ijrobp.2017.07.008","article-title":"Prospective, randomized study of radiation dose escalation with combined proton-photon therapy for benign meningiomas","volume":"99","author":"Sanford","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.06.018_b0200","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018333334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018333334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T13:46:32Z","timestamp":1550497592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018333334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0167814018333334"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.06.018","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}